Optimized donor management and organ preservation before kidney transplantation-Reference-Cited by-同舟云学术

Optimized donor management and organ preservation before kidney transplantation

Published:2015-12-09 Issue:9 Volume:29 Page:974-984
ISSN:0934-0874
Container-title:Transplant International
language:en
Short-container-title:Transpl Int

Author:

Mundt Heiko M.¹,Yard Benito A.¹,Krämer Bernhard K.¹,Benck Urs¹,Schnülle Peter¹

Affiliation:

1. 5th Department of Medicine (Nephrology/Endocrinology/Rheumatology); Medical Faculty Mannheim of the University of Heidelberg; University Hospital Mannheim; Mannheim Germany

Publisher

Frontiers Media SA

Subject

Transplantation

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/tri.12712/fullpdf

Reference127 articles.

1. Kidney transplantation in the elderly: a decision analysis;Jassal;J Am Soc Nephrol,2003

2. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant;Wolfe;N Engl J Med,1999

3. Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up;Schnuelle;J Am Soc Nephrol,1998

4. Systemic inflammation in the brain-dead organ donor;Barklin;Acta Anaesthesiol Scand,2009

5. Effects of brain death on organ quality and transplant outcome;Floerchinger;Transplant Rev,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Management after brain death/death by neurologic criteria for organ donation;Journal of the Japanese Society of Intensive Care Medicine;2022-12-01

2. Effects of polyethylene glycol-20k IV solution on donor management in a canine model of donor brain death;Biomedicine & Pharmacotherapy;2022-08

3. Association of Sequential Organ Failure Assessment (SOFA) components with mortality;Acta Anaesthesiologica Scandinavica;2022-04-10

4. Disparate Formulations for Machine Perfusion: A Survey of Organ Procurement Organizations’ Medication Additives and Outcome Analyses;Experimental and Clinical Transplantation;2021-11

5. Combination of mesenchymal stem cells and FK506 prolongs heart allograft survival by inhibiting TBK1/IRF3-regulated-IFN-γ production;Immunology Letters;2021-10